logo
I had the most common symptom of colon cancer in my early 30s. Here's why I got a (pricey) colonoscopy over a stool test.

I had the most common symptom of colon cancer in my early 30s. Here's why I got a (pricey) colonoscopy over a stool test.

Yahoo3 days ago
I had rectal bleeding, the most common symptom of colon cancer in people under 45.
I also had a family history of colon cancer, which pushed me to get a colonoscopy at 33.
My out-of-pocket colonoscopy cost is more than $1,000 so far, but I'm still glad I did it.
I paused, and then I clicked "cancel appointment."
The blood in my stool, the most common sign of colon cancer in young people, was going away. I chalked up my concerns to my job: I was interviewing colon cancer patients. Naturally, the symptoms were on my mind a lot.
But a year later, the bleeding kept coming back, and more prominently than before. Sometimes, I also had other colon cancer symptoms, such as inconsistent bowel movements. From writing more about colon cancer, I heard more stories of healthy young patients having barely any warning signs, only to be diagnosed at stage 4. And then, my grandfather was diagnosed with stage 1 colon cancer in late 2024.
I still had reservations about getting a colonoscopy. It seemed expensive and intense for just one symptom. At the same time, that symptom seemed to be getting worse after a year, and I now had a family history of colon cancer.
In the end, I got a colonoscopy and am so glad I did — even if I'm still navigating the financial side of it.
I booked a GI appointment after reading about stool tests, which can detect cancer via stool samples. It seemed minimally invasive while still taking some sort of action.
At my appointment, I'd hoped my age, lifestyle, and lack of more severe symptoms such as abdominal pain would sway my doctor to recommend the stool test over the colonoscopy.
But as a representative of Cologuard later told me, stool tests aren't recommended for screening people who have any symptoms. The representative also said they're meant for people ages 45 and older who are considered at average risk. This is because stool tests can detect only cancer itself. It was possible that I had precancerous polyps, for example, which wouldn't show up in a stool test but could be safely removed and biopsied in a colonoscopy. Plus, colonoscopies can identify other issues, such as hemorrhoids or inflammatory bowel disease, with symptoms similar to those of colon cancer.
My GI performed a quick rectal exam and didn't find anything. She said that given my age, the bleeding was probably caused by internal hemorrhoids or polyps, not cancer. She recommended I get a colonoscopy and some blood work to test my iron levels, which could also point to colon cancer. I booked a colonoscopy for three weeks later.
When my blood work came back normal, I wondered whether I was overreacting. Did I really need a colonoscopy?
For one, it was expensive. The procedure would cost $2,000 total without insurance. My GI explained that because my test was diagnostic and being done to examine colon cancer symptoms (as opposed to a standard colon cancer screening), it applied to my deductible. She also said the cost could vary based on my insurance plan, how far into the deductible I was, and where the colonoscopy was being done. Because I did mine at a free-standing endoscopy center instead of a hospital, it cut down on costs.
The estimate I got from my insurance company was about $813. That didn't include other potential fees such as biopsies. This is still lower than the national average cost for a colonoscopy, which starts at $1,250, and some of my coworkers under 45 were quoted closer to $2,000.
The idea of the procedure itself felt intense, too. I'd need to fast and take about $40 of laxatives and Gatorade the night before, undergo anesthesia, and have my husband pick me up. There were also very rare risks, such as tears to my colon.
A few times a week, I'd approach my husband forlornly, asking him whether he thought I was overreacting and should skip the procedure. Sadly, I learned the hard truth: No one could make this decision but me.
Postponing would be complicated, given our future plans to have kids: I can't get a colonoscopy once I'm pregnant because of risks to the fetus.
I realized I was fortunate: I had time to pre-plan and budget my colonoscopy, I could easily take a sick day from work, and my husband could take a few hours off from his job to pick me up. If I was going to do it, now was absolutely the best time.
Let's start with the bad news: Months after the procedure, I'm still dealing with insurance costs.
I made sure that my FSA funds, the pre-tax money I elected to set aside for medical costs, would cover at least most of the procedure and any extra fees. But because my receipt was missing information, the reimbursement for $813 was denied.
When I asked for a complete receipt, I was told I'd need to wait 30 to 60 days for my insurance to process my itemized statement. While I was waiting, I was mailed two more bills: $124.08 for a physician's processing fee and $125.40 for the anesthesia.
I'm holding on to them until I get reimbursed for the $813. Otherwise, I'd be paying more than $1,000 out of pocket, with no clarity on when I'll actually get the money back, if at all.
The good news: The colonoscopy itself went smoothly. Sure, induced bowel cleansing wasn't my idea of a riveting Wednesday night. But from speaking to people who've had colonoscopies, it sounds like it wasn't as unpleasant as chugging Golytely, a common colonoscopy prep medication.
The actual procedure took about 20 minutes, all of which I was out for.
Shortly after, my GI popped in to explain my results. It was a huge relief to have answers. Like she suspected, internal hemorrhoids, swollen veins in the anus and lower rectum, were causing the bleeding. Hemorrhoids are fairly common in young people, and activities such as lifting heavy weights can cause them. Looking back, the bleeding began around when I started strength training, and my GI confirmed that it could exacerbate the hemorrhoids. I can manage them by drinking more water, eating more fiber, and using hydrocortisone cream.
She also found and removed two polyps, one of which could have been precancerous because of its size. A few weeks later, a biopsy confirmed that the polyp was benign, and I don't have to get another colonoscopy until I'm 45 — the recommended starting age for colon cancer screenings.
As the rate of colorectal cancer rises among young people, there is a push for people to get their colon cancer symptoms checked out. But I can understand why anyone under the recommended screening age would skip a colonoscopy. Beyond the financial obstacle, it's not a quick procedure, and it requires a support system. It's easy to feel like spending time and money on what could be a benign result isn't worth the peace of mind.
Still, so many early signs of colon cancer are mild. Stories from colon cancer patients — the ones who only got diagnosed in late stages and had to navigate much more invasive treatments with lower chances of success — ultimately taught me that it's never worth taking a chance. It's a steep price to pay, but I'm glad I did.
July 2, 2025: This story was updated with information about the Cologuard stool test. It's usually recommended to people over 45 who have no symptoms and are considered at average risk for colon cancer.
Read the original article on Business Insider
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Can Gut Bacteria Be The Key To Banishing Forever Chemicals?
Can Gut Bacteria Be The Key To Banishing Forever Chemicals?

Yahoo

time37 minutes ago

  • Yahoo

Can Gut Bacteria Be The Key To Banishing Forever Chemicals?

Researchers at the University of Cambridge say they have identified a family of bacterial species that can help remove toxic PFAS, better known as 'forever chemicals.' PFAS (Perfluoroalkyl and Polyfluoroalkyl Substances) have been shown to cause health issues like decreased fertility, cardiovascular disease, developmental delays in children, and increased risk of certain cancers. Now, researchers say a microbe naturally found in the human gut may be able to absorb these forever chemicals and help remove them from the body. The researchers introduced nine of these bacterial species into the guts of mice in an attempt to 'humanize' the rodents' microbiomes. They found that the bacteria quickly absorbed PFAS that were consumed by the mice, which were then expelled in their feces. Notably, as more and more PFAS were introduced, the microbes worked harder, consistently helping withdraw the same percentage of the chemicals. Within just minutes of PFAS exposure, the bacteria accumulated between 25% and 74% of the chemicals. While the findings are promising, the results have yet to be verified in humans. The researchers aim to utilize the study's findings to develop probiotic dietary supplements that can enhance the levels of these microbes in the human gut. In May, The Dallas Express reported that the Environmental Protection Agency announced it would roll back limitations on certain PFAS in drinking water. Standards for PFOA and PFOS, two primary subtypes of PFAS, will remain at four parts per trillion; however, utilities will be given an extension to 2031 to comply with the limitation. Despite the health risks associated with PFAS, they remain ubiquitous in human environments, found in a wide range of products, including food packaging, waterproof clothing, and non-stick pans. Since they take thousands of years to break down, these forever chemicals continue to accumulate in both the environment and human bodies. 'Given the scale of the problem of PFAS 'forever chemicals', particularly their effects on human health, it's concerning that so little is being done about removing these from our bodies,' said Dr. Kiran Patil, of the University of Cambridge's MRC Toxicology Unit and senior author of the report.

Geographic Gaps in Maternity Care Cost Lives
Geographic Gaps in Maternity Care Cost Lives

Medscape

timean hour ago

  • Medscape

Geographic Gaps in Maternity Care Cost Lives

TOPLINE: Analysis of 14,772,210 live births revealed that counties designated as maternity care deserts faced significantly higher maternal mortality rates than those with full access to care. Desert counties showed a 36% higher risk for maternal death and a 26% increased risk for pregnancy-related mortality. METHODOLOGY: The analysis included county-level data from the CDC Wide-Ranging Online Data for Epidemiologic Research database from January 2018 to December 2021. A total of 14,772,210 live births were analyzed across four county categories: desert (n = 720,858), low access (n = 708,668), moderate access (n = 431,188), and full access (n = 12,911,496). Researchers restricted the study population to individuals aged 15-44 years to enhance accuracy and mitigate misclassification. Primary outcome measures included maternal mortality rate per 100,000 live births, with pregnancy-related mortality rate as a secondary outcome. TAKEAWAY: Desert counties showed significantly higher maternal mortality rates than full-access counties (32.25 vs 23.62 per 100,000 live births; absolute risk difference, 8.62; 95% CI, 4.63-12.61; adjusted incidence rate ratio [IRR], 1.36; 95% CI, 1.21-1.54). Desert counties also demonstrated higher pregnancy-related mortality rates than full-access counties (43.82 vs 34.72 per 100,000 live births; absolute risk difference, 9.10; 95% CI, 4.28-13.93; adjusted IRR, 1.26; 95% CI, 1.13-1.41). No significant differences in maternal or pregnancy-related mortality rates were found between low-access or moderate-access counties compared to full-access counties. IN PRACTICE: 'Maternity care deserts are associated with significantly higher rates of adverse maternal outcomes because limited access to skilled practitioners delays timely interventions during critical stages of pregnancy and childbirth,' the authors of the study wrote. SOURCE: This study was led by Tetsuya Kawakita, MD, MS, from the Department of Obstetrics and Gynecology at the Macon and Joan Brock Virginia Health Sciences at Old Dominion University in Norfolk, Virginia. It was published online in Obstetrics & Gynecology. LIMITATIONS: Fatalities temporally linked to pregnancy, such as homicide, suicide, or drug overdose, were often coded as external causes on death certificates and may have been excluded from the CDC pregnancy-related mortality classification. The surge in mortality during the COVID pandemic may have accentuated existing disparities. The cross-sectional analysis precluded causal inferences regarding relationships between maternity care access and maternal outcomes. The definition of maternity care practitioners did not include family physicians who might have provided obstetric services in rural areas. Additionally, the maternity care access measure did not capture the intra-county spatial distribution of services, potentially masking access barriers in geographically extensive or sparsely populated rural counties. DISCLOSURES: This study received support from the Eastern Virginia Medical School Junior Clinical Investigator Program. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

5Strands' Pet Test Demonstrates Wellness Benefits in 3rd Party Study
5Strands' Pet Test Demonstrates Wellness Benefits in 3rd Party Study

Associated Press

timean hour ago

  • Associated Press

5Strands' Pet Test Demonstrates Wellness Benefits in 3rd Party Study

Pet parents across the U.S. are increasingly seeking answers to unexplained skin irritation, digestive distress, and behavioral changes in their pets. With growing awareness of food intolerances and environmental sensitivities, the demand for personalized, non-invasive wellness solutions is rising fast. 5Strands is leading the way with their pet intolerance, sensitivity, and imbalances tests, designed to help pet owners make smarter choices to restore their pet's health and vitality. But, for solutions to truly stand out in a crowded market, science-backed validation is essential. That's where consumer perception studies come into play; offering real-world insight into how products perform in everyday settings. For 5Strands, this kind of research not only supports their product claims but builds trust within the pet health community. In a recent consumer perception study conducted by Citruslabs, the Pet Intolerances & Imbalances Test demonstrated notable improvements in pets' vitality, digestion, and behavior after owners adjusted their pets' diets and environments based on the test results. By Day 45 of using the product: - 81.3% of participants said they would use the test again for other pets. - 71.9% agreed that the test allowed them to make changes that improved their pet's life. - 68.8% would recommend the test to friends and family. - 62.5% of pets experienced no upset stomachs in the last 15 days (up from 44.4% at Baseline). - 81.25% of pets experienced no diarrhea (up from 63.9%), and 65.63% experienced no vomiting (up from 55.6%). 'These results are a strong affirmation of what we hear from customers every day: our test helps pets feel better,' said Austin Collins, CEO at 5Strands. 'We're proud to offer a tool that empowers pet owners to take their pet's health into their own hands with clarity and confidence' Unlike conventional pet wellness products that treat symptoms without addressing root causes, 5Strands' test identifies potential intolerances and imbalances, ranging from food ingredients to environmental factors, so that pet owners can create tailored plans to improve their pets' overall health and comfort. The test also scored highly on user-friendliness: - 100% of participants said the instructions were easy to follow. - 69.4% agreed the test report clear and easy to understand. - 61.1% were able to interpret the results without veterinary assistance. In addition to improvements in digestive and skin health, owners observed increased eagerness to eat and reduced signs of discomfort such as excessive scratching, chewing, or biting of irritated areas. As more pet parents demand proactive, personalized health insights, 5Strands continues to innovate with science at their core. The Citruslabs study confirms that the Pet Intolerances & Imbalances Test is more than just a diagnostic tool, it's a trusted solution for the future of pet wellness. To learn more about 5Strands' pet intolerance, sensitivity, and imbalance tests, visit About 5Strands Founded to revolutionize pet and human health diagnostics, 5Strands offers non-invasive hair testing that uncovers potential intolerances to food and environmental triggers. With easy-to-understand results and actionable insights, 5Strands empowers families to take control of their wellness journeys. Learn more at Media Contact Company Name: 5Strands Contact Person: Lisa Blaurock Email: Send Email Phone: +1 (833) 600-8378 Country: United States Website: Source: Brand Push

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store